Physician profile
Jesse M Sheldon
NPI 1073140190
$1,930.83
in general payments reported to CMS, 2019-2025
19 companies · $737 in 2025
The $737 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $78.04 · 2023: $401 · 2024: $715 · 2025: $737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,852.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $468.00 | 2023-2025 | |
| Pfizer INC. | $282.77 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $210.99 | 2023-2025 | Belbuca, Xtampza |
| Spr Therapeutics, INC | $186.42 | 2023-2024 | Sprint Pns System |
| Globus Medical, INC. | $107.93 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $107.07 | 2024-2025 | Relistor |
| Nevro Corp. | $81.30 | 2024 | Senza |
| Scilex Pharmaceuticals INC. | $78.62 | 2024-2025 | |
| Saluda Medical Americas, INC. | $70.14 | 2025 | Evoke |
| Mml US, INC. | $66.82 | 2025 | Reactiv8 |
| Biohaven Pharmaceutical Holding Company LTD. | $47.83 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $37.58 | 2025 | |
| Lundbeck LLC | $37.47 | 2025 | Vyepti |
| Impel Pharmaceuticals INC. | $36.74 | 2023 | Trudhesa |
| Allergan, INC. | $30.21 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $21.32 | 2025 | Aristada, Lybalvi |
| Medtronic, INC. | $20.75 | 2023 | Intellis Adaptivestim |
| Bioventus LLC | $20.01 | 2023 | Supartz Fx Sodium Hyaluronate |
| Axsome Therapeutics, INC. | $18.86 | 2025 | Symbravo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Sheldon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.